For immediate release
Radiant Genomics, Inc. Awarded an SBIR Phase I Grant
Emeryville, CA, June 11, 2014 – Radiant Genomics, Inc. is pleased to announce it has been awarded a Phase I Small Business Industrial Research (SBIR) grant from the National Institute on Aging, part of the National Institutes of Health, for the project titled “A synthetic biology platform to identify novel anti-aging natural products.”
“We are pleased by the continued support of our technology by the SBIR program,” said Dr. Jeffrey Kim, CSO of Radiant Genomics, Inc. “With this grant award, we believe Radiant will be strongly positioned to execute on its goals and will demonstrate the power of our technology and approach to identify and produce truly novel and valuable natural products”.
About the Company
Radiant Genomics, Inc. was founded in 2012 with the goal of integrating a range of novel technologies including large-scale sequencing, synthetic biology, bioinformatics, cloud computing, metabolic engineering, and high-throughput analytical chemistry to develop a robust industrial platform for natural product discovery, diversification, and production. Radiant Genomics utilizes this platform to develop products in numerous market categories including pharmaceuticals, agriculture, specialty chemicals, and nutraceuticals.